Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy

The importance of tumor size measurements as predictors of disease recurrence after radical prostatectomy in patients with prostate carcinoma remains somewhat controversial, and many pathologists do not report these measurements routinely. The authors studied the correlation between the visual estimate of the percentage of carcinoma in prostatic tissue from radical prostatectomy specimens and prostate carcinoma recurrence rates in a series of 595 patients who underwent radical prostatectomy.

[1]  P. Humphrey,et al.  Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens. , 1990, Human pathology.

[2]  D. Grignon,et al.  Workgroup 3: Current prognostic factors and their relevance to staging , 1996, Cancer.

[3]  T. Therneau,et al.  Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy. , 1989, The Journal of urology.

[4]  A. Partin,et al.  Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. , 1989, The Journal of urology.

[5]  P. Humphrey,et al.  Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate‐specific antigen levels , 1993, Cancer.

[6]  A S Whittemore,et al.  Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer , 1993, Cancer.

[7]  P. Lange.  Editorial: Prognostic Factors and Clinical Significance of Cancers Detected by Screening: Growth Rate and Progression of Prostate Cancer , 1994 .

[8]  J. McNeal.  Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. , 1992, Human pathology.

[9]  G. Miller,et al.  Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration. , 1994, The Journal of urology.

[10]  R T Vollmer,et al.  Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[11]  P. Humphrey,et al.  Percentage of free serum prostate-specific antigen as a predictor of pathologic features of prostate cancer in a screening population. , 1998, Urology.

[12]  A. Shibata.  The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimens , 1999, Cancer.

[13]  D. Bostwick,et al.  Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density. , 1994, The Journal of urology.

[14]  A W Partin,et al.  Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. , 1993, The Journal of urology.

[15]  D. Grignon,et al.  Pathologic staging of prostate carcinoma: What are the issues? , 1996, Cancer.

[16]  D. Bostwick,et al.  Staging of early prostate cancer: a proposed tumor volume-based prognostic index. , 1993, Urology.

[17]  D. Bostwick,et al.  Recommendations for the reporting of resected prostate carcinomas. Association of Directors of Anatomic and Surgical Pathology. , 1996, American journal of clinical pathology.

[18]  T. Stamey,et al.  Morphometric and clinical studies on 68 consecutive radical prostatectomies. , 1988, The Journal of urology.

[19]  W. Catalona.  Nerve-sparing radical retropubic prostatectomy. , 1985, The Urologic clinics of North America.

[20]  L. True,et al.  Surgical pathology examination of the prostate gland. Practice survey by American society of clinical pathologists. , 1994, American journal of clinical pathology.

[21]  D. Johnston,et al.  Prostate specific antigen and pathological features of prostate cancer in black and white patients: a comparative study based on radical prostatectomy specimens. , 1998, The Journal of urology.

[22]  P. Humphrey,et al.  Histologic Grade, DNA Ploidy, and Intraglandular Tumor Extent as Indicators of Tumor Progression of Clinical Stage B Prostatic Carcinoma: A Direct Comparison , 1991, The American journal of surgical pathology.

[23]  D. Henson,et al.  Practice protocol for the examination of specimens removed from patients with carcinoma of the prostate gland. A publication of the cancer committee, college of american pathologists. Task Force on the Examination of Specimens Removed From Patients With Prostate Cancer. , 1994, Archives of pathology & laboratory medicine.

[24]  P. Troncoso,et al.  Tumor volume and prostate specific antigen: implications for early detection and defining a window of curability. , 1995, The Journal of urology.

[25]  T. Stamey,et al.  Biological determinants of cancer progression in men with prostate cancer. , 1999, JAMA.

[26]  T. Stamey,et al.  The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. , 1994, The Journal of urology.

[27]  P. Walsh,et al.  Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C). , 1994, The Journal of urology.

[28]  P. Walsh,et al.  Pathological factors that influence prognosis in stage A prostatic cancer: the influence of extent versus grade. , 1981, The Journal of urology.